What is the dosing frequency for Diphenhydramine (Benadryl) administered via intravenous push (IVP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diphenhydramine (Benadryl) IVP Dosing Frequency

For adults, diphenhydramine can be administered intravenously at 25-50 mg per dose, with a maximum daily dosage of 400 mg, divided into multiple doses as needed. 1

Adult Dosing

  • Standard IV dose: 25-50 mg per dose administered at a rate not exceeding 25 mg/minute 1
  • Maximum daily dosage: 400 mg 1
  • For acute hypersensitivity reactions: 25-50 mg administered parenterally (IV push) 2
  • For treatment of dystonic reactions: 25-50 mg IV 2

Pediatric Dosing

  • 1-2 mg/kg/dose or 5 mg/kg/24 hours divided into four doses 1
  • Maximum daily dosage: 300 mg 1
  • Administration rate should generally not exceed 25 mg/minute 1
  • For acute hypersensitivity reactions: 1-2 mg/kg per dose 2

Administration Considerations

  • IV administration should be slow, generally not exceeding 25 mg/minute to minimize adverse effects 1
  • When administering via IVP, monitor for cardiovascular effects including hypotension and cardiac arrhythmias 3
  • Rapid IV administration may precipitate seizures in some patients 2

Clinical Cautions

  • Diphenhydramine can cause sedation and respiratory suppression, especially when combined with other sedative agents 2
  • In patients with allergic reactions, diphenhydramine should be considered second-line therapy to epinephrine and should never be administered alone in the treatment of anaphylaxis 2
  • Cardiac monitoring is recommended during IV administration, particularly in patients with cardiovascular disease 3
  • A case report documented cardiac arrest in an infant with congenital heart disease following IV diphenhydramine administration, highlighting the need for caution in vulnerable populations 3

Special Populations

  • For elderly patients, consider using lower doses due to increased sensitivity to anticholinergic effects and greater risk of adverse reactions 1
  • In patients with hepatic impairment, dose reduction may be necessary due to decreased drug metabolism 1

Common Pitfalls

  • Administering too rapidly (faster than 25 mg/minute), which increases risk of hypotension and arrhythmias 1
  • Exceeding maximum daily dose recommendations (400 mg for adults, 300 mg for children) 1
  • Using diphenhydramine as first-line treatment for anaphylaxis instead of epinephrine 2
  • Failing to monitor patients for respiratory depression, especially when combined with other sedatives 2

Remember that diphenhydramine should be individualized according to patient needs and response, with careful monitoring for adverse effects, particularly when administered intravenously 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiac Arrest Following the Administration of Intravenous Diphenhydramine for Sedation to an Infant With Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.